The PCPT trial
The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...
| Autors principals: | , |
|---|---|
| Format: | Journal article |
| Idioma: | French |
| Publicat: |
2008
|